Thursday, July 9, 2026

biotech · Alzheimer Disease · Friedreich Ataxia · LXEO

Lexeo Therapeutics

Lexeo Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

New York, USA HQ
2018 Founded
91 Employees
Public company Type
LXEO · NYSE Ticker
Company details
Status
Public
HQ
New York, USA
Founded
2018
Employees
91
Programs
3
Drugs
4
Patents
0
Intelligence · Clinical Trials

Lexeo Therapeutics clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Lexeo Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Lexeo Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Lexeo Therapeutics.

  1. Low dose LX2006 — Phase 2

    Clinical update
  2. LX2020 — Phase 2

    Clinical update
  3. LX1001 — Phase 1

    Clinical update

Trial registry

3 studies